A Clinical Trial of Antiplatelets in Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The purpose of this study is to determine the effect of antiplatelet therapy on theendovascular phenotype in psoriasis, specifically whether clopidogrel reduces vascularendothelial pro‐atherosclerotic transcript expression more than aspirin or placebo. Theprimary endpoint is mean change in a composite endothelialpro‐inflammatory/pro‐atherosclerotic transcript expression signature measured frombrachial vein endothelial cells.
Epistemonikos ID: f361d6e28cc9f15f98450006e662d09cb844dc5f
First added on: Aug 05, 2026